Literature DB >> 8893737

Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury. Case report.

T Ingebrigtsen1, B Romner.   

Abstract

The authors studied 24 patients with a Glasgow Coma Scale score of 14 or 15 and normal computerized tomography scans after minor head injury. The study protocol included obtaining serial measurements of S-100 protein in serum during the first 12 hours after injury and early magnetic resonance (MR) imaging. Four patients (17%) had detectable levels of S-100 protein in serum. The S-100 protein levels were highest immediately after trauma, declining hour by hour. In two patients, MR imaging revealed intracranial contusion. Levels of S-100 protein were not detectable in serum in one patient with MR-verified cerebral contusion, but the first measurements were made late, 6 hours after trauma. The highest serum level of S-100 protein (0.9 microgram/L) was seen in a 73-year-old man 2 hours after injury. Magnetic resonance imaging revealed a contusion of the left cerebellar hemisphere, and the patient suffered permanent sequelae of impaired posture and dizziness.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8893737     DOI: 10.3171/jns.1996.85.5.0945

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  18 in total

1.  Shoulder surgery in the beach chair position is associated with diminished cerebral autoregulation but no differences in postoperative cognition or brain injury biomarker levels compared with supine positioning: the anesthesia patient safety foundation beach chair study.

Authors:  Andrew Laflam; Brijen Joshi; Kenneth Brady; Gayane Yenokyan; Charles Brown; Allen Everett; Ola Selnes; Edward McFarland; Charles W Hogue
Journal:  Anesth Analg       Date:  2015-01       Impact factor: 5.108

Review 2.  Potential Blood-based Biomarkers for Concussion.

Authors:  Linda Papa
Journal:  Sports Med Arthrosc Rev       Date:  2016-09       Impact factor: 1.985

3.  Serologic markers of brain injury and cognitive function after cardiopulmonary bypass.

Authors:  Basel Ramlawi; James L Rudolph; Shigetoshi Mieno; Kamal Khabbaz; Neel R Sodha; Munir Boodhwani; Sue E Levkoff; Edward R Marcantonio; Frank W Sellke
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

4.  Elevated S100B and neuron specific enolase levels in patients with migraine-without aura: evidence for neurodegeneration?

Authors:  Nurgul Yilmaz; Kamil Karaali; Sebahat Ozdem; Mehtap Turkay; Ali Unal; Babur Dora
Journal:  Cell Mol Neurobiol       Date:  2011-02-04       Impact factor: 5.046

5.  Serum S100beta protein as a marker of disease activity in patients with malignant melanoma.

Authors:  M Q Mohammed; H D Abraha; R A Sherwood; K MacRae; S Retsas
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

6.  Biomarkers in the clinical diagnosis and management of traumatic brain injury.

Authors:  Georgene W Hergenroeder; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

7.  Role of Neuroprotein S-100B in the Diagnostic of Pediatric Mild Brain Injury.

Authors:  Annelie-Martina Weinberg; Christoph Castellani
Journal:  Eur J Trauma Emerg Surg       Date:  2010-07-12       Impact factor: 3.693

8.  [Identification of high-risk patients after minor craniocerebral trauma. Measurement of nerve tissue protein S 100].

Authors:  P Biberthaler; T Mussack; K-G Kanz; U Linsenmaier; K-J Pfeifer; W Mutschler; M Jochum
Journal:  Unfallchirurg       Date:  2004-03       Impact factor: 1.000

9.  Acute effects of intracranial hypertension and ARDS on pulmonary and neuronal damage: a randomized experimental study in pigs.

Authors:  Jan Florian Heuer; Paolo Pelosi; Peter Hermann; Christina Perske; Thomas A Crozier; Wolfgang Brück; Michael Quintel
Journal:  Intensive Care Med       Date:  2011-05-05       Impact factor: 17.440

10.  Application of blood-based biomarkers in human mild traumatic brain injury.

Authors:  Alex P Di Battista; Shawn G Rhind; Andrew J Baker
Journal:  Front Neurol       Date:  2013-05-01       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.